Retour
Prix Akeso, Inc. (AKESF)
Graphique du cours de l'action AKESF
AKESF Prévision du cours des actions
Akeso, Inc.
$12.85
1.02%
$0.12
À la fermeture : Feb 13, 16:00:00 GMT-5
$14.1
9.72%
$1.25
Post-Marché: Feb 13, 18:20:15 GMT-5
Statistiques clés
Clôture préc.
$12.72
Prix d'ouverture
$14.1
Plage de la journée
$14.1 - $14.1
Plage de 52 semaines
$6.81 - $23.15
Volume
100
Volume moyen
1.1K
BPA (TTM)
-0.14
Rendement en dividend
--
Capitalisation boursière
$12.9B
Qu’est-ce que AKESO INC. ?
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.